This section will maintain key information and medical advancements relating to cancer – how to prevent it and what treatments are available.
Not every new story - just major breakthroughs and studies on ways to prevent. Particularly will be focusing on research results in humans - lots of promising treatments unfortunately never make it from the lab, through human trials, and onto the market.
Did you know? A handful of your cells turn cancerous EVERY DAY - but your immune system tracks them down and kills them before they turn into large-scale cancer.
BioNTech - Company developing patient-specific immunotherapies for cancer.
Melanoma Institute Australia - Institute dedicated to preventing and curing melanoma through world-class research, treatment and education programs.
Kite Pharma - Company that develops cancer immunotherapy products.
Optellum - Early lung cancer intervention.
Vaccitech - Vaccine research centre.
Oncotarget - Bio-medical journal covering research on all aspects of oncology.
National Cancer Center Research Institute - Leading Japan’s cancer treatment, prevention, control programs, research and education
National Cancer Institute (NCI) - Institute for cancer research.
Moffitt Cancer Center - Nonprofit cancer treatment and research center.
European Journal of Cancer (EJC) - Scientific journal providing information about research on cancer.More Cancer resources
Cancer Blog Posts
SkinVision App Review – Instant Spot/Mole Assessment
19-Feb-2020 Provides an early warning or peace of mind – good value for money either way
Highly specific and effective anti-cancer custom nanoparticle
Nano Magazine - 08-Jul-2020
Able to regress tumor in mice within one to two days, and prevent regrowthRead more...
Naked mole-rat's immune system is resistant to cancer
Independent - 02-Jul-2020
Their extreme biology could be key to preventing cancer in humansRead more...
This therapy attacks solid-tumor cancer cells in mice, humans
EurekAlert! - 29-Jun-2020
CAR-T therapy, a proven approach, now improved to broaden potential targetsRead more...